Gossamer Bio Inc (GOSS)
0.8793
-0.01
(-0.79%)
USD |
NASDAQ |
Nov 05, 16:00
0.8793
0.00 (0.00%)
After-Hours: 19:03
Gossamer Bio Revenue (Quarterly): 95.84M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 95.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
95.84M
Minimum
Jun 2024
95.84M
Maximum
Jun 2024
95.84M
Average
95.84M
Median
Jun 2024
Revenue (Quarterly) Benchmarks
| Bioxytran Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.40M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.23M |
| Total Expenses (Quarterly) | 43.76M |
| EPS Diluted (Quarterly) | 0.22 |
| Enterprise Value | 43.07M |
| Profit Margin (Quarterly) | 51.37% |
| Earnings Yield | -37.53% |